| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 27 |
| 1 | MACITENTAN | 11 |
| 2 | SILDENAFIL CITRATE | 10 |
| 3 | TADALAFIL | 10 |
| 4 | AMBRISENTAN | 8 |
| 5 | FUROSEMIDE | 7 |
| 6 | SILDENAFIL | 7 |
| 7 | BOSENTAN | 6 |
| 8 | POTASSIUM CHLORIDE | 6 |
| 9 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE | 1 | 0.0400 |
| 1 | EPOPROSTENOL | 27 | 0.0021 |
| 2 | DACOMITINIB | 1 | 0.0013 |
| 3 | NAFCILLIN SODIUM | 1 | 0.0011 |
| 4 | ANIDULAFUNGIN | 1 | 0.0006 |
| 5 | SIPULEUCEL-T | 2 | 0.0003 |
| 6 | TOPOTECAN | 2 | 0.0003 |
| 7 | CODEINE SULFATE | 1 | 0.0003 |
| 8 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN | 1 | 0.0003 |
| 9 | DOBUTAMINE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 30 |
| 1 | Endothelin Receptor Antagonist [EPC] | 18 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 16 |
| 3 | Corticosteroid [EPC] | 14 |
| 4 | Loop Diuretic [EPC] | 12 |
| 5 | Alkylating Drug [EPC] | 7 |
| 6 | Osmotic Laxative [EPC] | 7 |
| 7 | Aldosterone Antagonist [EPC] | 6 |
| 8 | Benzodiazepine [EPC] | 6 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 2 | 0.0003 |
| 2 | Cannabinoid [EPC] | 2 | 0.0002 |
| 3 | Prostacycline Vasodilator [EPC] | 30 | 0.0002 |
| 4 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 5 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 16 | 0.0001 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |